Consideration of anticancer therapeutic agents in early gastric cancer / 中国实用外科杂志

ABSTRACT

Early gastric cancer is mainly treated withradical resection by either endoscopic resection or radical surgery. but there arestill patients finally developrecurrence and metastasis. There are arguments on how to identify these patients with poor prognosis,and how to manage the treatment,and the value and timing ofanticancer therapeutic agents. Because of low level of evidence, the current clinical guidelines are relatively vague on these questions, and oncologists differ in treatment optionin real world. The role of anticancer therapeutic agents in early gastric cancer needs to be re-examined given the advances in molecular biology,bioinformatics and new drugs.